Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
10/2012
10/18/2012US20120264715 Substituted bicyclic methyl amine derivatives as sphingosine-1 phosphate receptors modulators
10/18/2012US20120264714 Boron-containing small molecules as anti-inflammatory agents
10/18/2012US20120264706 Purine derivatives as adenosine a1 receptor agonists and methods of use thereof
10/18/2012US20120264704 Substituted dihydropyrazolones and use thereof as hif-prolyl-4 -hydroxylase inhibitors
10/18/2012US20120264694 Composition comprising torasemide
10/18/2012US20120264693 Compounds acting as peptide gap junction modulators, and uses thereof
10/18/2012US20120264677 Oxidant resistant apolipoprotein a-1 and mimetic peptides
10/18/2012US20120264676 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress
10/18/2012US20120264675 Cmv gene products promote cancer stem cell growth
10/18/2012US20120264674 Methods for preparing purified polypeptide compositions
10/18/2012US20120263789 Delayed release rasagiline formulation
10/18/2012US20120263786 Pharmaceutical Formulations Containing an SGLT2 Inhibitor
10/18/2012US20120263778 Polyurethane urea for stent coatings
10/18/2012US20120263765 Agents from cells
10/18/2012US20120263759 Coating Comprising An Elastin-Based Copolymer
10/18/2012US20120263747 Albumin-Fused Anti-Angiogenesis Peptides
10/18/2012US20120263733 Anti-cxcl9, anti-cxcl10, anti-cxcl11, anti-cxcl13, anti-cxcr3 and anti-cxcr5 agents for inhibition of inflammation
10/18/2012US20120263729 Compositions and methods for treating cardiovascular disease
10/18/2012US20120263721 Therapeutic Combination and Methods of Treatment With a DLL4 Antagonist and an Anti-Hypertensive Agent
10/18/2012US20120263712 Pyrrolidine-1,2-dicarboxamide derivatives
10/18/2012US20120263710 Administering anti-placental growth factor antibodies
10/18/2012US20120263702 Human Aminoacyl-tRNA Synthetase Polypeptides Useful For The Regulation of Angiogenesis
10/18/2012US20120263695 Composition having strains of lactobacillus fermentum
10/18/2012US20120263686 Compositions and improved soft tissue replacement methods
10/18/2012US20120263682 Cardiac muscle repair or regeneration using bone marrow-derived stem cells
10/18/2012US20120263679 Combinations Comprising Heterocyclic Inhibitors of MEK and Methods of Use Thereof
10/18/2012US20120263675 Bivalent diazo bicyclic smac
10/18/2012US20120263673 Compositions and methods for reducing the risk of preeclampsia
10/18/2012US20120263670 Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
10/18/2012US20120263657 Promoting Whole Body Health
10/18/2012US20120263653 Methods and systems for generating nanoparticles
10/18/2012US20120263648 Rna nanoparticles and nanotubes
10/18/2012DE102011017208A1 Bivalirudin und andere Hirudin-Analoga zur Konservierung der zellulären Funktionalität in der klinischen Zelltherapie Bivalirudin and other hirudin analogues for the preservation of cellular functionality in clinical cell therapy
10/18/2012DE102011016875A1 Zubereitung enthaltend DISC1 und/oder mindestens ein DISC1-Fragment zur Anwendung bei der therapeutischen Behandlung des menschlichen oder tierischen Körpers Preparation comprising DISC1 and / or at least one DISC1 fragment for use in the therapeutic treatment of the human or animal body
10/18/2012DE102011007272A1 Verzweigte 3-Phenylpropionsäure-Derivate und ihre Verwendung Branched 3-phenylpropionic acid derivatives and their use
10/18/2012CA2833180A1 Novel piperidinyl monocarboxylic acids as s1p1 receptor agonists
10/18/2012CA2833043A1 Use of s-adenosylmethionine, vitamin e, and vitamin c for the prevention and treatment of cardiovascular dysfunction
10/18/2012CA2832970A1 Branched 3-phenylpropionic acid derivatives and the use thereof
10/18/2012CA2832758A1 Antihypertensive pharmaceutical composition
10/18/2012CA2832467A1 1,3 oxazines as bace1 and/or bace2 inhibitors
10/18/2012CA2829676A1 Cycloalkenyl aryl derivatives for cetp inhibitor
10/17/2012EP2511366A1 Agent for promoting differentiation of pluripotent stem cells into cardiac muscle cells which includes nitrovin
10/17/2012EP2511275A1 Novel piperidinyl monocarboxylic acids as S1P1 receptor agonists
10/17/2012EP2510956A1 Adipocyte sheet, three-dimensional structure thereof, and method for producing the same
10/17/2012EP2510942A1 Use of natriuretic peptide for treating heart failure
10/17/2012EP2510939A1 Anti-connexin peptide mimetics and therapeutic uses thereof
10/17/2012EP2510938A1 Anti-connexin antisense compounds and use thereof for treating vascular disorders
10/17/2012EP2510937A1 Anti-connexin compounds and use thereof in combination with transplant or grafting procedures
10/17/2012EP2510927A2 Use of dha, epa or dha-derived epa for treating a pathology associated with cellular oxidative damage
10/17/2012EP2509980A1 Heterocyclic compounds containing an indole core
10/17/2012EP2509957A1 Cysteine protease inhibitors
10/17/2012EP2509956A1 Cysteine protease inhibitors
10/17/2012EP2509942A2 Bis-acylated hydroxylamine derivatives
10/17/2012EP2509941A2 N-acylated hydroxylamine derivatives and o-acylated hydroxylamine derivatives
10/17/2012EP2509591A1 Methods and compositions for treating disease or condition related to orexin receptor 1, orexin receptor 2, somatostatin receptor 2 or dopamine d2l receptor
10/17/2012CN1948274B Verakanol derivative, preparation method and use thereof
10/17/2012CN1922171B Pyrimidine derivative
10/17/2012CN102741246A Novel polymorphic shapes of methyl{4,6-diamino-2-[1-(2-fluorobenzyl)-1h-pyrazolo[3,4-b]pyridine-3-yl]pyrimidin-5-yl)carbamate
10/17/2012CN102740894A Sdf-1 delivery for treating ischemic tissue
10/17/2012CN102740870A Compositions and preparation methods of compositions for prevention and treatment of hypertension
10/17/2012CN102740860A Read through inducer, and therapeutic agent for nonsense-mutation-type genetic diseases
10/17/2012CN102740857A Complex formulation comprising aspirin coated with barrier containing hydrophobic additive, and hmg-coa reductase inhibitor
10/17/2012CN102740844A Combination of droloxifene and clopidogrel
10/17/2012CN102732474A Compound for inhibiting mycobacterium tuberculosis, screening method and uses thereof
10/17/2012CN102731666A Method for extracting polysaccharide from cordyceps militaris medium
10/17/2012CN102731658A Tat PTD-Endostatin recombination protein, preparation method and application thereof
10/17/2012CN102731597A Abelmoschus manihot extract and novel application of chemical components thereof
10/17/2012CN102731574A Thienopyridine alpha-amino benzylphosphonate, preparation method and application thereof
10/17/2012CN102731510A Derivatives of ticagerlor, and preparation method and pharmaceutical application thereof
10/17/2012CN102731499A Lactam compounds and their use as pharmaceuticals
10/17/2012CN102731459A Scutellarin aglycone Mannich derivatives, and preparation method and application thereof
10/17/2012CN102731413A Urea compound and its preparation method, intermediate and use
10/17/2012CN102731400A Novel ivabradine hydrochloride crystal form and its preparation method and use in preparation of pharmaceutical composition
10/17/2012CN102731379A N- (hetero)aryl, 2- (hetero)aryl-substituted acetamides for use as wnt signaling modulators
10/17/2012CN102731308A Method for preparing salvianolic acid A bulk drug
10/17/2012CN102731283A Compound grandifoliol, its preparation method and its application
10/17/2012CN102731279A Method for preparing 6-gingerol and 8-gingerol from ginger
10/17/2012CN102727872A Anti-aging and heart and blood vessel protecting soft capsule and preparation method thereof
10/17/2012CN102727863A Combined drug of compound fermented Cordyceps sinensis powder and ginsenoside Rg1
10/17/2012CN102727862A Delapril hydrochloride-Chuanxiong oil nanoemulsion antihypertensive drug
10/17/2012CN102727851A Chinese herbal medicine used for treating cardiovascular and cerebrovascular diseases
10/17/2012CN102727842A Extract product of ginger and extraction method thereof
10/17/2012CN102727841A Gingerol extract product, its extraction method and its application
10/17/2012CN102727829A Traditional Chinese medicine preparation used for treating cutaneous hemangioma
10/17/2012CN102727823A Medicine for postoperative rehabilitation of cerebral hemorrhage
10/17/2012CN102727766A Traditional Chinese medicinal preparation for treating comprehensive hemorrhoids, and preparation method thereof
10/17/2012CN102727762A Related ingredient combination with function of relaxing vessels in traditional Chinese medicine for reducing blood pressure
10/17/2012CN102727727A Oil-in-water type sodium nitroprusside-garlic oil nanoemulsion antihypertensive drug
10/17/2012CN102727723A Traditional Chinese herbal rectal administration capsule for treating hemorrhoids
10/17/2012CN102727721A Benazepril hydrochloride-hyacinth oil nanoemulsion antihypertensive drug
10/17/2012CN102727713A Use of Liuwei dihuang preparation in preparations of treatment drugs for treating patients after heart stent surgeries
10/17/2012CN102727691A Collateral-dredging heart-comforting pellets
10/17/2012CN102727682A Traditional Chinese medicine composition for treating cerebrovascular disease and preparation method thereof
10/17/2012CN102727672A Traditional Chinese medicine composition for treating hypertensive renal disease and its preparation method
10/17/2012CN102727670A Oil-in-water type terazosin-grape seed oil antihypertensive drug
10/17/2012CN102727663A Application of Pu'er tea extract in preparing hypotensive medicine or foodstuff
10/17/2012CN102727661A Capsule for alleviating hangover and protecting liver and preparation method thereof
10/17/2012CN102727653A Preparation method and active site of pharmaceutical composition used for controlling acute coronary syndrome
10/17/2012CN102727647A A health care formula for foot bath
10/17/2012CN102727643A Medicine for treating hemorrhoid and alleviating ache and oedema after haemorrhoidectomy and preparation method thereof